l-Arginine improves endothelial function, independently of arginine uptake, in aortas from chronic renal failure female rats
- 15 February 2014
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 306 (4) , F449-F456
Abstract
Endothelial cell dysfunction (ECD) is a common feature of chronic renal failure (CRF). Defective nitric oxide (NO) generation due to decreased endothelial nitric oxide synthase (eNOS) activity is a crucial parameter characterizing ECD. Decreased activity of cationic amino acid transporter-1 (CAT-1), the selective arginine transporter of eNOS, has been shown to inhibit eNOS in uremia. Recently, we failed to demonstrate a decrease in glomerular arginine transport in uremic female rats (Schwartz IF, Grupper A, Soetendorp H, Hillel O, Laron I, Chernichovski T, Ingbir M, Shtabski A, Weinstein T, Chernin G, Shashar M, Hershkoviz R, Schwartz D. Am J Physiol Renal Physiol 303: F396–F404, 2012). The current experiments were designed to determine whether sexual dimorphism which characterizes glomerular arginine transport system in uremia involves the systemic vasculature as well and to assess the effect of l-arginine in such conditions. Contractile and vasodilatory responses, ultrastructural changes, and measures of the l-arginine-NO system were performed in thoracic aortas of female rats subjected to ⅚ nephrectomy. The contractile response to KCl was significantly reduced, and acetylcholine-induced vasodilation was significantly impaired in aortas from CRF dames compared with healthy rats. Both of these findings were prevented by the administration of arginine in the drinking water. The decrease in both cGMP generation, a measure of eNOS activity, and aortic eNOS and phosphorylated eNOS abundance observed in CRF rats was completely abolished by l-arginine, while arginine transport and CAT-1 protein were unchanged in all experimental groups. Arginine decreased both serum levels of advanced glycation end products and the asymmetrical dimethylarginine/arginine ratio and restored the endothelial ultrastructure in CRF rats. In conclusion. arginine administration has a profound beneficial effect on ECD, independently of cellular arginine uptake, in CRF female rats.Keywords
This publication has 36 references indexed in Scilit:
- Hormonal modulation of endothelial NO productionPflügers Archiv - European Journal of Physiology, 2010
- Sexual dimorphism in glomerular arginine transport affects nitric oxide generation in old male ratsAmerican Journal of Physiology-Renal Physiology, 2009
- Rosiglitazone improves aortic arginine transport, through inhibition of PKCα, in uremic ratsAmerican Journal of Physiology-Renal Physiology, 2008
- Oral Administration of Both Tetrahydrobiopterin and L-Arginine Prevents Endothelial Dysfunction in Rats With Chronic Renal FailureJournal of Cardiovascular Pharmacology, 2007
- Arginine uptake is attenuated through modulation of cationic amino-acid transporter-1, in uremic ratsKidney International, 2006
- Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification-A role in pathogenesis and antiproliferative chemotherapyGeneral Pharmacology: The Vascular System, 1996
- Macula densa derived nitric oxide in regulation of glomerular capillary pressureKidney International, 1996
- L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans.Journal of Clinical Investigation, 1992
- Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failureThe Lancet, 1992
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980